Lite Strategy, Inc. FY 2026: Net loss $(71.2M), EPS $(2.06) — 10-K Summary

Lite Strategy, Inc. reported a net loss of $71.2M for FY 2026, worsening from a $15.9M loss in FY 2025, with no revenue in either year. The company pivoted to Litecoin (LTC) as its primary reserve strategy, discontinuing oncology programs and focusing on non-oncologic R&D. Management initiated share repurchases and a covered call options program to manage capital and LTC exposure.

Original reporting
Published Sep 28, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lite Strategy, Inc. FY 2026: Net loss $(71.2M), EPS $(2.06) — 10-K Summary — source image
Decision brief

The 30-second read

$LITSBearishLow
01

Why it matters

The disclosed loss and crypto shift may trigger share repurchases and covered‑call activity, but overall sentiment remains bearish.

02

Market read

Primary relevance is to LITS shareholders; broader market impact is limited.

03

What to watch

Potential regulatory scrutiny of crypto‑treasury practices and the impact of covered‑call program on cash flow.

Relevance 6/10Novelty 6/10Timing: post‑market release

Background

Lite Strategy, Inc. is a micro‑cap biotech that recently raised $100M via a PIPE and pivoted to a Litecoin treasury.

Company-level read

Ticker impact

$LITSBearishMedium confidence
Context

Lite Strategy, Inc. disclosed a FY 2026 net loss of $71.2M, widening from $15.9M loss in FY 2025, with zero revenue and a shift to a Litecoin treasury.

Expected impact

downward pressure as investors price in the expanded loss and crypto‑treasury risk

Evidence & confidence

Losses grew 340% YoY and the company now holds a volatile LTC position, likely prompting sell‑offs.

Market effects

Highlights risk for small‑cap biotech firms adding crypto exposure to balance sheets.

Limited to U.S. micro‑cap investors; no broader regional effect.

Minimal; primarily a company‑specific disclosure.

Counterpoint

If Litecoin appreciates sharply, the treasury could offset losses, offering a speculative upside.

Key entities

  • Lite Strategy, Inc.

    Biotech firm with new crypto treasury strategy.

  • GSR

    Provider of covered‑call arrangements for Lite Strategy.

Related articles

$AZIOMedAI 8/10

Azio AI 3Q 2026: Revenue $1.87M, EPS ($0.34) — 10-Q Summary

Azio AI reported 3Q 2026 revenue of $1.87M, up 3.3% YoY, and a net loss of $0.34 per share, narrowed 9.7%. Sales were driven by medical supplies to a related party, while higher G&A costs, including a $860,428 stock-based compensation adjustment, offset gains from debt settlement. AI infrastructure segment generated no revenue.

$PANWHighAI 9/10

Palo Alto Networks Reports Fiscal First Quarter 2027 Financial Results

Palo Alto Networks Inc (PANW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Palo Alto Networks Reports Fiscal First Quarter 2027 Financial Results SANTA CLARA, Calif., Nov. 18, 2026 — Palo Alto Networks ® (NASDAQ: PANW), the global AI cybersecurity leader, announced today financial results for its fiscal first quarter ended October 31, 2026.